← All trials
NCT04997317
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 21, 2021
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Aug 9, 2021
- Last posted
- Aug 9, 2021
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of BaselLead sponsor
- University of BaselOverall official - principal investigator
- Swiss Cancer LeagueCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.